Mocroft A, Lundgren J, Monforte AA, Ledergerber B, Barton S, Vella S, et al. Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe study group. Int J Epidemiol. 1997;26(2):400–7.
Marie-Renée B, Drouin O, Bartlett G, Nguyen Q, Low A, Gavriilidis G, et al. Incidence and prevalence of opportunistic and other infections and the impact of antiretroviral therapy among HIV-infected children in low-and middle-income countries: a systematic review and meta-analysis. Clin Infect Dis. 2016;62(12):1586–94.
Tanuma J, Lee KH, Haneuse S, Matsumoto S, Nguyen DT, Nguyen DTH, et al. Incidence of AIDS-defining opportunistic infections and mortality during antiretroviral therapy in a cohort of adult HIV-infected individuals in Hanoi, 2007-2014. PLoS One. 2016;11(3):e0150781.
Rubaihayo J, Tumwesigye NM, Konde-Lule J. Trends in prevalence of selected opportunistic infections associated with HIV/AIDS in Uganda. BMC Infect Dis. 2015;15(1):1.
Buchacz K, Baker RK, Palella FJ Jr, Chmiel JS, Lichtenstein KA, Novak RM, et al. AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study. AIDS. 2010;24(10):1549–59.
Schwarcz L, Chen M-J, Vittinghoff E, Hsu L, Schwarcz S. Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance. AIDS. 2013;27(4):597–605.
Djawe K, Buchacz K, Hsu L, Chen M-J, Selik RM, Rose C, et al. Mortality risk after AIDS-defining opportunistic illness among HIV-infected persons—San Francisco, 1981–2012. J Infect Dis. 2015;212(9):1366–75.
Akgün KM, Tate JP, Pisani M, Fried T, Butt AA, Gibert CL, et al. Medical ICU admission diagnoses and outcomes in human immunodeficiency virus–infected and virus–uninfected veterans in the combination antiretroviral era. Crit Care Med. 2013;41(6):1458.
Uhlenkott MC, Buskin SE, Kahle EM, Barash E, Aboulafia DM. Causes of death in the era of highly active antiretroviral therapy: a retrospective analysis of a hybrid hematology-oncology and HIV practice and the Seattle/king county adult/adolescent spectrum of HIV-related diseases project. Am J Med Sci. 2008;336(3):217–23.
Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43(1):27–34.
Kim JH, Psevdos G Jr, Gonzalez E, Singh S, Kilayko MC, Sharp V. All-cause mortality in hospitalized HIV-infected patients at an acute tertiary care hospital with a comprehensive outpatient HIV care program in new York City in the era of highly active antiretroviral therapy (HAART). Infection. 2013;41(2):545–51.
Honge BL, Jespersen S, Aunsborg J, Mendes DV, Medina C, da Silva Te D, et al. High prevalence and excess mortality of late presenters among HIV-1, HIV-2 and HIV-1/2 dually infected patients in Guinea-Bissau - a cohort study from West Africa. Pan Afr Med J. 2016;25:40.
Drain PK, Losina E, Parker G, Giddy J, Ross D, Katz JN, et al. Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa. PLoS One. 2013;8(1):e55305.
Mocroft A, Lundgren JD, Sabin ML, Monforte A, Brockmeyer N, Casabona J, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the collaboration of observational HIV epidemiological research Europe study (COHERE). PLoS Med. 2013;10(9):e1001510.
Sabin CA, Smith CJ, Gumley H, Murphy G, Lampe FC, Phillips AN, et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS. 2004;18(16):2145–51.
Brannstrom J, Svedhem Johansson V, Marrone G, Wendahl S, Yilmaz A, Blaxhult A, et al. Deficiencies in the health care system contribute to a high rate of late HIV diagnosis in Sweden. HIV Med. 2016;17(6):425–35.
Perbost I, Malafronte B, Pradier C, Santo L, Dunais B, Counillon E, et al. In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection? HIV Med. 2005;6(4):232–9.
O'Connell S, Enkelmann J, Sadlier C, Bergin C. Late HIV presentation - missed opportunities and factors associated with a changing pattern over time. Int J STD AIDS. 2017;28(8):814–21.
Xiao J, Gao G, Li Y, Zhang W, Tian Y, Huang Y, et al. Spectrums of opportunistic infections and malignancies in HIV-infected patients in tertiary care hospital, China. PLoS One. 2013;8(10):e75915.
Gebo KA, Fleishman JA, Moore RD. Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states. J Acquir Immune Defic Syndr. 2005;40(5):609–16.
Mirani G, Williams PL, Chernoff M, Abzug MJ, Levin MJ, Seage GR, et al. Changing trends in complications and mortality rates among US youth and young adults with HIV infection in the era of combination antiretroviral therapy. Clin Infect Dis. 2015;61(12):1850–61.
Centers for Disease Control DoH, R.O.C. (Taiwan). HIV/AIDS http://www.cdc.gov.tw/english/info.aspx?treeid=e79c7a9e1e9b1cdf&nowtreeid=e02c24f0dacdd729&tid=7D01A79F5FD3B63D. Accessed 10 Dec 2017.
Centers for Disease Control DoH, R.O.C. (Taiwan). AIDS Control Program http://www.cdc.gov.tw/english/info.aspx?treeid=9d909a43ebf2819d&nowtreeid=0a4848283dfe9c40&tid=3DD1C7FFFF550913. Accessed 10 Dec 2017.
Hung C-C, Chen M-Y, Hsieh S-M, Sheng W-H, Chang S-C. Clinical spectrum, morbidity, and mortality of acquired immunodeficiency syndrome in Taiwan: a 5-year prospective study. J Acquir Immune Defic Syndr. 2000;24(4):378–85.
Sun H, Chen M, Hsieh S, Sheng W, Chang S, Hsiao C, et al. Changes in the clinical spectrum of opportunistic illnesses in persons with HIV infection in Taiwan in the era of highly active antiretroviral therapy. Jpn J Infect Dis. 2006;59(5):311.
Yang CH, Huang YF, Hsiao CF, Yeh YL, Liou HR, Hung CC, et al. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005. HIV Med. 2008;9(7):535–43.
Lesko CR, Cole SR, Zinski A, Poole C, Mugavero MJ. A systematic review and meta-regression of temporal trends in adult CD4+ cell count at presentation to HIV care, 1992–2011. Clin Infect Dis. 2013;57(7):1027–37.
Barry SM, Lloyd-Owen SJ, Madge SJ, Cozzi-Lepri A, Evans AJ, Phillips AN, et al. The changing demographics of new HIV diagnoses at a London Centre from 1994 to 2000. HIV Med. 2002;3(2):129–34.
Selik RM, Mokotoff ED, Branson B, Owen SM, Whitmore S, Hall HI. Centers for Disease Control and Prevention (CDC). Revised surveillance case definition for HIV infection—United States, 2014. MMWR Recomm Rep. 2014;63:1–0.
Braun DL, Kouyos RD, Balmer B, Grube C, Weber R, Günthard HF. Frequency and spectrum of unexpected clinical manifestations of primary HIV-1 infection. Clin Infect Dis. 2015;61(6):1013–21. civ398
Centers for Disease Control. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41(RR-17):1–19.
Sun HY, Chen MY, Hsiao CF, Hsieh SM, Hung CC, Chang SC. Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active anti-retroviral therapy. Clin Microbiol Infect. 2006;12(4):381–8.
Skarbinski J, Rosenberg E, Paz-Bailey G, Hall HI, Rose CE, Viall AH, et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern Med. 2015;175(4):588–96.
Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20(10):1447–50.
Guillon M, Celse M, Geoffard PY. Economic and public health consequences of delayed access to medical care for migrants living with HIV in France. Eur J Health Econ. 2018;19(3):327–40.
Chen YJ, Lee CM, Chen M, Chuang SY, Liu HF, Wong WW, et al. Molecular epidemiology of HIV-1 infection in Taiwan from 2005 to 2008: further spread of CRF07_BC and emergence of CRF07_BC/subtype B dual infection. J Acquir Immune Defic Syndr. 2012;59(5):438–46.
Chen YM, Kuo SH. HIV-1 in Taiwan. Lancet. 2007;369(9562):623–5.
Yang CH, Yang SY, Shen MH, Kuo HS. The changing epidemiology of prevalent diagnosed HIV infections in Taiwan, 1984-2005. Int J Drug Policy. 2008;19(4):317–23.
Lin T, Chen CH, Chou P. Effects of combination approach on harm reduction programs: the Taiwan experience. Harm Reduct J. 2016;13(1):23.
Dokubo EK, Kim AA, Le LV, Nadol PJ, Prybylski D, Wolfe MI. HIV incidence in Asia: a review of available data and assessment of the epidemic. AIDS Rev. 2013;15(2):67–76.
van Griensven F, JWdL VW. A review of the epidemiology of HIV infection and prevention responses among MSM in Asia. AIDS. 2010;24:S30–40.
Beyrer C, Sullivan PS, Sanchez J, Dowdy D, Altman D, Trapence G, et al. A call to action for comprehensive HIV services for men who have sex with men. Lancet. 2012;380(9839):424–38.
Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, et al. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009;52(2):280–9.
Desta WG, Sinishaw MA. Factors Affecting Utilization of Voluntary HIV Counseling and Testing Services among Teachers in Awi Zone, Northwest Ethiopia. AIDS Res Treat. 2017;2017:9034282.
Patel RR, Patel S, Clarke E, Khan AW, Doshi B, Radcliffe KW. Guidance and practice on frequency of HIV and sexually transmitted infection testing in men who have sex with men - what is the European situation? Int J STD AIDS. 2014;25(3):213–8.
Zablotska I, Holt M, de Wit J, McKechnie M, Mao L, Prestage G. Gay men who are not getting tested for HIV. AIDS Behav. 2012;16(7):1887–94.
Ransome Y, Batson A, Galea S, Kawachi I, Nash D, Mayer KH. The relationship between higher social trust and lower late HIV diagnosis and mortality differs by race/ethnicity: results from a state-level analysis. J Int AIDS Soc. 2017;20(1):1–9.
Bertrand T, Chan PA, Howe K, Comella J, Marak T, Bandy U. Health Equity, Social justice, and HIV in Rhode Island: a contemporary challenge. R I Med J. 2016;99(11):21–4.
Gesesew HA, Tesfay Gebremedhin A, Demissie TD, Kerie MW, Sudhakar M, Mwanri L. Significant association between perceived HIV related stigma and late presentation for HIV/AIDS care in low and middle-income countries: a systematic review and meta-analysis. PLoS One. 2017;12(3):e0173928.
Shangani S, Escudero D, Kirwa K, Harrison A, Marshall B, Operario D. Effectiveness of peer-led interventions to increase HIV testing among men who have sex with men: a systematic review and meta-analysis. AIDS Care. 2017;29(8):1003–13.
Sullivan AK, Raben D, Reekie J, Rayment M, Mocroft A, Esser S, et al. Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study). PLoS One. 2013;8(1):e52845.
Wolff B, Nyanzi B, Katongole G, Ssesanga D, Ruberantwari A, Whitworth J. Evaluation of a home-based voluntary counselling and testing intervention in rural Uganda. Health Policy Plan. 2005;20(2):109–16.
Lyu SY, Morisky DE, Yeh CY, Twu SJ, Peng EY, Malow RM. Acceptability of rapid oral fluid HIV testing among male injection drug users in Taiwan, 1997 and 2007. AIDS Care. 2011;23(4):508–14.
Lazarus JV, Hoekstra M, Raben D, Delpech V, Coenen T, Lundgren JD. The case for indicator condition-guided HIV screening. HIV Med. 2013;14(7):445–8.
Althoff KN, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, et al. Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis. 2010;50(11):1512–20.
Centers for Disease Control DoH, R.O.C. (Taiwan). Statistics of Communicable Diseases and Surveillance Report 2010 http://www.cdc.gov.tw/professional/infectionreportinfo.aspx?treeid=56ca56252a0fa705&nowtreeid=2AA8435E1709FBFB&tid=A64090AD33AEA54B. Accessed 10 Dec 2017.
Centers for Disease Control DoH, R.O.C. (Taiwan). Statistics of Communicable Diseases and Surveillance Report 2011 http://www.cdc.gov.tw/professional/infectionreportinfo.aspx?treeid=56ca56252a0fa705&nowtreeid=2AA8435E1709FBFB&tid=E6F157600F310E3D. Accessed 10 Dec 2017.
Centers for Disease Control DoH, R.O.C. (Taiwan). Statistics of Communicable Diseases and Surveillance Report 2012 http://www.cdc.gov.tw/professional/infectionreportinfo.aspx?treeid=56ca56252a0fa705&nowtreeid=2AA8435E1709FBFB&tid=464F496EE012F03C. Accessed 10 Dece 2017.
Centers for Disease Control DoH, R.O.C. (Taiwan). Statistics of Communicable Diseases and Surveillance Report 2013 http://www.cdc.gov.tw/professional/infectionreportinfo.aspx?treeid=56ca56252a0fa705&nowtreeid=2AA8435E1709FBFB&tid=F811D601B49E2955. Accessed 10 Dec 2017.
Centers for Disease Control DoH, R.O.C. (Taiwan). Statistics of Communicable Diseases and Surveillance Report 2014 http://www.cdc.gov.tw/professional/infectionreportinfo.aspx?treeid=56ca56252a0fa705&nowtreeid=2AA8435E1709FBFB&tid=15B0DEB6406CAF71. Accessed 10 Dec 2017.
Centers for Disease Control DoH, R.O.C. (Taiwan). Statistics of Communicable Diseases and Surveillance Report 2015 [http://www.cdc.gov.tw/professional/infectionreportinfo.aspx?treeid=56ca56252a0fa705&nowtreeid=2AA8435E1709FBFB&tid=2535D9B0B8D8C633]. Accessed 10 Dec 2017.
Waters L, Sabin CA. Late HIV presentation: epidemiology, clinical implications and management. Expert Rev Anti-Infect Ther. 2011;9(10):877–89.
Girardi E, Sabin CA, Monforte AD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr. 2007;46(Suppl 1):S3–8.